ASGE Esophagology: Tailoring Management from Testing to Treatment (On-Demand) | July 2022-Risk Stratification of Screening in Barretts Esophagus

Video Transcription

Video Summary

The video transcript is a lecture on Barrett's esophagus, esophageal cancer, and complications. The speaker, Prasad Iyer, is a professor of medicine and director of the esophageal interest group at the Mayo Clinic. He discusses risk stratification of screening and surveillance in Barrett's esophagus. Under screening, he covers current recommendations for Barrett's screening, Barrett's and esophageal adenocarcinoma risk assessment scores, and challenges in implementation. Under surveillance, he discusses factors associated with progression in Barrett's, clinical risk progression scores, biomarkers for surveillance and risk stratification, and challenges in implementation. He also mentions various risk assessment scores and their accuracy in predicting the presence of Barrett's esophagus. Additionally, he discusses the use of biomarkers for predicting progression to high-grade dysplasia or esophageal cancer. He mentions the challenges in implementing these tests and the need for validation and standardization. Overall, the lecture focuses on the importance of risk assessment in screening and surveillance for Barrett's esophagus and the potential role of biomarkers in improving prediction and management.

Asset Subtitle

Dr. Prasad Iyer

Keywords

Barrett's esophagus

esophageal cancer

risk stratification

screening

surveillance

biomarkers